Prescription Required
Tribet 2 Tablet ER is a combination medication designed to manage type 2 diabetes mellitus. Each tablet contains Glimepiride (2mg), Metformin (500mg), and Pioglitazone (15mg), which work synergistically to control blood sugar levels. This combination is particularly beneficial for individuals whose blood glucose levels are not adequately managed by diet, exercise, or monotherapy.
By enhancing insulin sensitivity, increasing insulin secretion, and reducing hepatic glucose production, Tribet 2 Tablet ER helps prevent complications associated with diabetes, such as neuropathy, nephropathy, and retinopathy.
Patients with liver disorders should use Tribet 2 Tablet ER with caution. Liver function tests should be conducted periodically to monitor for potential hepatic side effects.
This medication should be used cautiously in patients with kidney impairment. Regular monitoring of kidney function is recommended, and dosage adjustments may be necessary based on renal function.
Consuming alcohol while on Tribet 2 Tablet ER can increase the risk of hypoglycemia (low blood sugar) and lactic acidosis. It's advisable to limit or avoid alcohol intake during treatment.
Tribet 2 Tablet ER can cause hypoglycemia, leading to dizziness or drowsiness. If you experience these symptoms, avoid driving or operating heavy machinery until your blood sugar levels stabilize.
The use of Tribet 2 Tablet ER during pregnancy is not recommended due to potential risks to the developing fetus. Consult your healthcare provider for alternative treatments if you are pregnant or planning to become pregnant.
Components of this medication may pass into breast milk and could harm a nursing infant. It's essential to discuss with your doctor whether to discontinue breastfeeding or the medication.
Tribet 2 Tablet ER is a combination of three antidiabetic medicines—Glimepiride (2mg), Metformin (500mg), and Pioglitazone (15mg)—that work together to effectively manage blood sugar levels. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, aiding in glucose regulation. Metformin, a biguanide, reduces glucose production in the liver and enhances insulin sensitivity, ensuring better glucose utilization by the body. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity in muscle and fat cells, helping to reduce insulin resistance. This synergistic action provides comprehensive blood sugar control, minimizing the risk of diabetes-related complications and promoting overall metabolic health.
Type 2 diabetes is a chronic condition where the body either does not produce enough insulin or becomes resistant to insulin, leading to high blood sugar levels. Over time, uncontrolled diabetes can cause serious complications like nerve damage, kidney disease, heart problems, and vision loss. Managing diabetes with medications, lifestyle changes, and regular monitoring is essential for long-term health.
Tribet 2 Tablet ER is a combination medicine that provides effective blood sugar control in type 2 diabetes. It works through multiple mechanisms, helping the body use insulin efficiently and reducing glucose production. When combined with a healthy diet and lifestyle changes, Tribet 2 can help prevent long-term diabetes complications and improve overall well-being. Always take the medication as prescribed and monitor your blood sugar levels regularly.
Content Updated on
Thursday, 13 Feburary, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA